EHMTI-0021. The possible effect of telmisartan on the blood-brain barrier transport of verapamil

Documenti analoghi

• The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1
  di: Saaby, Lasse, et al.
  Pubblicazione: (2015)
• EHMTI-0125. Studying the permeability of the blood-brain barrier during migraine attacks using [11C]-dihydroergotamine
  di: Schankin, C, et al.
  Pubblicazione: (2014)
• EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
  di: Pavbro, P, et al.
  Pubblicazione: (2014)
• EHMTI-0016. Examples of problematic use of references in the headache literature. A problem for readers, authors, referees, and editors ?
  di: Tfelt-Hansen, P
  Pubblicazione: (2014)
• EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
  di: Tfelt-Hansen, P, et al.
  Pubblicazione: (2014)